Please assess the completion status of the following clinical trial:

Trial Title: Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults, age 18 - 69 years~* Ability to read and understand English~* Subjectively in good health~* Able to stand without assistance for \~10 minutes~Exclusion Criteria:~* Any volunteer with relocation, deployment, or release from active duty in the next 4 months~* Pregnant, or currently breastfeeding, females~* Anyone with chronic health problems (e.g. kidney disease, liver disease, intestinal malabsorption)~* Any volunteer currently taking vitamin D supplementation~* Taking medications for an endocrine disorder, such as Synthroid or oral hypoglycemic agents~* Sarcoidosis~* Medications having a high potential for interaction with vitamin D:~anti-seizure medications, cyclosporine, indinavir (Crixivan) • Adults diagnosed with light allergies: Actinic prurigo, Polymorphous light eruption, Solar urticaria~• Adults diagnosed with light sensitivities: Protoporphyria, Photodermatitis, Xeroderma pigmentosum, Lupus erythematosus, Actinic dermatitis, UV-sensitive syndrome

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: t

Study Arms:
- Standing Phototherapy Kiosk (SPK) (Type: EXPERIMENTAL): Volunteers assigned to this group were administered phototherapy treatments in a standing phototherapy kiosk once every other week, for 10 weeks. The treatment usually lasts no more than 10 minutes and is based on the Fitzpatrick skin type classification tool, which is self-reported via the computer touch screen in the kiosk.
- Oral Supplement (Type: ACTIVE_COMPARATOR): Volunteers assigned to this group were provided with a 10-week supply (70 pills) of a vitamin D3 supplement. Consented subjects were instructed to take one 600 IU pill by mouth each day for ten weeks. They were instructed to take this with a meal. This dose is the RDA for adults between 18 and 70 years old according to the Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D and Calcium.

Based on this trial design, predict the completion outcome and termination type (if applicable).